INVENTAGE LAB, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,480 KRW | +0.77% |
|
+0.29% | -39.77% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
More news
| 1 day | +0.77% | ||
| 1 week | +0.29% | ||
| Current month | -1.50% | ||
| 1 month | -1.13% | ||
| 3 months | -12.81% | ||
| 6 months | -26.04% | ||
| Current year | -39.77% |
1 week
10 310.00
10 800.00
1 month
9 400.0011 200.00
Current year
9 400.0021 400.00
1 year
8 710.0032 750.00
3 years
8 440.0032 750.00
5 years
8 440.0032 750.00
10 years
8 440.0032 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ju-Hee Kim
CEO | Chief Executive Officer | - | 15-05-13 |
Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -39.77% | 64.69M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- A389470 Stock